Correction: Learn from international recommendations and experiences of countries that have successfully implemented monoclonal antibody prophylaxis for prevention of RSV infection
Saved in:
| Main Authors: | Sara Manti, Eugenio Baraldi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | Italian Journal of Pediatrics |
| Online Access: | https://doi.org/10.1186/s13052-025-01901-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring parental perspectives: Maternal RSV vaccination versus infant RSV monoclonal antibody
by: Bryony Treston, et al.
Published: (2024-12-01) -
Optimal implementation of an Ontario nirsevimab program for respiratory syncytial virus (RSV) prophylaxis: Recommendations from a provincial RSV expert panel
by: Bosco Paes, et al.
Published: (2024-12-01) -
The Effect of Clinical Decision Support System on the Success of Respirative Syncytial Virus (RSV) Prophylaxis
by: Gizem Karkın Tozlu, et al.
Published: (2025-04-01) -
Increased Risk of RSV Infection in Children with Down's Syndrome: Clinical Implementation of Prophylaxis in the European Union
by: Dianne van Beek, et al.
Published: (2013-01-01) -
It is time anti-CGRP monoclonal antibodies be considered first-line prophylaxis for migraine
by: Gabriel Taricani Kubota
Published: (2022-08-01)